Certified by Founder Lodge
Corteria Pharmaceuticals
France - Paris
START UP
1 Disclosed Funding Rounds $69,471,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Development of transformative therapies for the treatment of worsening and acute decompensated heart failure
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 07 ,2023 | Series A | $69,471,000 |
Omnes
OrbiMed
Kurma Partners
JEITO
Fountain Healthcare Partners
V-Bio Ventures
Invivo Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Balerion AI | $6,000,000 | (Apr 17, 2026)
Solidroad | $25,000,000 | (Apr 17, 2026)
Worki.ai | $2,750,000 | (Apr 17, 2026)
Beeline Medicines | $300,000,000 | (Apr 17, 2026)
Ethermed | $8,500,000 | (Apr 17, 2026)
